Close Menu

NEW YORK (GenomeWeb News) – A consortium of European research partners will use €9.5 million ($12.3 million) from the EU to trawl the trenches of the deep seas in search of organisms that could be used to develop bioactive compounds for treating diseases and for nutritional and cosmetic applications.

Led by researchers at the University of Aberdeen and the University of Leuven, the 24 PharmSea initiative partners from 14 countries will collect and screen mud and sediment samples from deep oceanic trenches to discover those compounds, KU Leuven said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.